The Role of Ubiquitination and Sumoylation in Diabetic Nephropathy

Abstract EN

Diabetic nephropathy (DN) is a common and characteristic microvascular complication of diabetes; the mechanisms that cause DN have not been clarified, and the epigenetic mechanism was promised in the pathology of DN.

Furthermore, ubiquitination and small ubiquitin-like modifier (SUMO) were involved in the progression of DN.

MG132, as a ubiquitin proteasome, could improve renal injury by regulating several signaling pathways, such as NF-κB, TGF-β, Nrf2-oxidative stress, and MAPK.

In this review, we summarize how ubiquitination and sumoylation may contribute to the pathology of DN, which may be a potential treatment strategy of DN.